Overview
This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.
Description
Patellar tendinopathy, also known as Jumper's knee, is the most common pathology in elite sports, with 30% of diagnoses occurring in volleyball. Among elite volleyball players, the prevalence of this overuse-related condition ranges between 40% and 50%, resulting in anterior knee pain during daily and recreational activities, which can lead to deficits in strength and sports performance. To date, investigator can determine whether a patient has had a history of tendinopathy through modifications in biomechanical jump-landing strategies. However, there is a lack of early biomechanical markers to identify the onset of patellar tendinopathy and thus prevent its chronic progression. A preventive strategy using markerless motion capture technology, providing quantitative and visual feedback of a 3D human body model, shows promise. Investigators hypothesize that jump-landing kinematic analysis using markerless technology could identify early kinematic markers specific to patellar tendinopathy, distinguishing affected individuals from a non-tendinopathy population. This could ultimately help identify motor strategies following the onset of patellar tendinopathy A prospective longitudinal multicenter cohort. After signing the consent form, participants will undergo a medical examination, including a clinical assessment, a SLDS test, a Doppler ultrasound of the patellar tendon, and evaluation using the VISA-PF and OSTRC-P scores. Following a standardized 10-minute warm-up, participants will perform vertical jump tests captured by high-resolution cameras, analyzed using markerless motion capture technology. These assessments will be conducted at inclusion and at 3, 6, 9, and 12 months. Additional medical visits will occur if symptoms arise outside of testing.
Eligibility
- Subject aged between 18 and 45 years
- Male subject
- Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year.
- Participants affiliated with or covered by a social security scheme
SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP
Patients with at least 2 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP
Patients with 0 or 1 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
Non inclusion Criteria:
- Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
- Contraindications to participating in sports activities
- Other pathologies involving the lower limbs (\< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
- Participants who have not given their informed consent
- Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
- Participants deprived of their liberty by judicial or administrative decision
